Cellectis - ADR

XNAS:CLLS  
4.75
-0.09 (-1.86%)
4:04:56 PM EDT: $4.75 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)476.54M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.26 Million
Adjusted EPS-$0.30
See more estimates
10-Day MA$4.64
50-Day MA$4.20
200-Day MA$2.61
See more pivots

Cellectis - ADR Stock, XNAS:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 222
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.